紫金錠이 간암세포주 HepG2의 세포고사 및 세포주기에 미치는 영향
Induction of Apoptosis and Cell Cycle Arrest by Jageum-Jung in HepG2 Hepatoma Cells
1
조회
0
다운로드
6
인용
0
참고문헌
초록
Abstract
Objectives : Jageum-Jung is used as an anti-cancer agent in oriental medicine, but the mechanism by which it induces cell death in cancer cells is still unclear. The purpose of this study was to investigate the effects of Jageum-Jung on apoptosis and cell cycle arrest in HepG2 hepatoma cells.Methods : Various cancer cell lines including HepG2, C6 glioma, SH-SY5Y, PANC-1, and MCF-7 cells, were used. Apoptosis was determined by DAPI nuclei staining and flow cytometry in HepG2 cells treated with various concentrations (from 25 to 200 ㎍/㎖) of H2O extract of Jageum-Jung (JGJ) for 48 hrs. Expression of cell cycle arrest mediators including Rb, p53, p21, cyclin B1, cdk4, and cyclin E proteins were measured by Western blot analysis. To estimate intracellular hydrogen peroxide levels and intracellular nitric oxide levels, HepG2 cells were stained with DCFH-DA dye and DAF dye, subjected on flow cytometric analysis. Results : 1. Jageum-Jung decreased the viability of HepG2 cells in a dose-dependent manner.2. Jageum-Jung induced the catalytic activation of caspase-3 in HepG2 cells.3.. Jageum-Jung increased the intracellular hydrogen peroxide and NO in HepG2 cells.4. Jageum-Jung increased the expression of Rb, p53 and p21 in HepG2 cells.5. Jageum-Jung induced the expression of cyclin B1, cdk4, and cyclin E in HepG2 cells.Conclusions : Taken together, we suggest that Jageum-Jung exhibits cytotoxic effects on HepG2 cells, causing apoptosis and cell cycle arrest. The results showed that Jageum-Jung may do so by regulating the expression of specific target molecules that promote efficient apoptotic cell death following G2/M phase arrest in a dose-dependent manner.
참고문헌 (22)
- "the significance of apoptosis", pp.251~306 (1980)
- "distinct modes of cell death with fundamentally different significance", pp.229~2 59 (1982)
- "Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the Uterine Cervix", 82, pp.238~246 (2001)
- "抗癌中藥方選", pp.196~ (1995), 人民軍醫出版社
- "婦科腫瘤中醫調治集萃", pp.136~137 (1995), 厦門大學出版社
- "實用抗癌方劑", pp.100~102 (1998), 中國醫藥科技出版社
- "紫金錠의 解毒效能에 關한 文獻的 考察" (1979), 대구한의과대학교 제한동의학술원
- "紫金錠의 抗腫瘍效果에 對한 考察", 10(2), pp.73~81 (2002)
- , 1999, 69~107, pp.도서출판 한우리
- "抗癌劑 및 放射線 副作用에 대한 韓方療法", 9, pp.239~64 (1994)
- "方藥合編解說", pp.504~505 (2005), 성보사
- "韓藥의 藥理", pp.105~ (2000), 고려의학
- "腫瘍病良方1500首", pp.131~ (1999), 中國中醫藥出版社
- "現代實用抗癌中藥", pp.396~397 (1999), 北京科學技術出版社
- "Invovement of the CD95 (APO-1", Fas) receptor, pp.1996, 2[DOI]
- "Mechanism controlling cellular suicide-role of Bcl-2 and caspases", 54, pp.427~445 (1998)
- "Caspase-dependent Cleavage of signaling proteins during apoptosis", 273(12), pp.7141~7147 (1998)
- "11q13 amplification in local recurrence of human primary breast cancer", 12, pp.128~133 (1995)
- "Cancer cell cycles", 274, pp.1672~1677 (1996)
- "Inhibitors of mammalian G1 cyclin-dependent kinases", 9, pp.1149~1163 (1995)
- "Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions : immunocytochemical and quantitative image analyses", 150, pp.15~23 (1997)
- "Transforming growth factor beta 1-inducing apoptosis in human ovarian carcinoma cells: protection by the antioxidant N-acetylcysteine and Bcl-2", 7, pp.1095~1104 (1996)